Download - Global Codes of Ethics/Conduct Roundtable Discussion

Transcript
Page 1: Global Codes of Ethics/Conduct  Roundtable Discussion

1

Global Codes of Ethics/Conduct Roundtable Discussion

International Medical Device Compliance Congress and Best Practices Forum

May 27, 2008Paris

Christopher L. White, Esq., Executive Vice President, General Counsel, and Assistant Secretary

Page 2: Global Codes of Ethics/Conduct  Roundtable Discussion

2

Overview

I. Where Are We?

II. Where Are We Going?

Page 3: Global Codes of Ethics/Conduct  Roundtable Discussion

3

AdvaMed’s Commitment to Compliance Excellence

I. Where are We?

• 2003 – Revised and Reissued AdvaMed Code of Ethics

• 2005 – AdvaMed Supplementary FAQs • 2006 – AdvaMed Code Logo program • 2006 – AdvaMed–OIG communications on entities where physicians have both an ownership interest and generate substantial revenues• 2008 – AdvaMed Supports Kohl Legislation; ”appropriate” disclosure of device company-physician relationships • Code Revisions Currently Underway

Page 4: Global Codes of Ethics/Conduct  Roundtable Discussion

4

AdvaMed Code of Ethics

Voluntary Code Effective January 1, 2004 Purpose is to encourage voluntary, ethical interactions

between AdvaMed members and health care professionals Code should be interpreted in light of principle that

AdvaMed Members:• Encourage ethical business practices and responsible

industry conduct• Shall not use unlawful inducement to sell, lease, etc.

their products “Health Care Professionals” defined as:

• Individuals or entities that purchase, lease, recommend, use, arrange for the purchase or lease of, or prescribe Members’ products in the U.S.

Independent surveys show wide industry adoption

I. Where Are We?

Page 5: Global Codes of Ethics/Conduct  Roundtable Discussion

55

AdvaMed Code of EthicsI. Preamble

II. Member-Sponsored Product Training and Education

III. Supporting Third Party Educational Conferences

IV. Sales and Promotional Meetings

V. Arrangements with Consultants

VI. Gifts

VII. Provision of Reimbursement and Other Economic Information

VIII. Grants and Charitable Donations

Also, includes a series of Frequently Asked Questions

I. Where Are We?

Page 6: Global Codes of Ethics/Conduct  Roundtable Discussion

66

Code of Ethics Logo

• Available to any medical technology company whose CEO signs a licensing agreement (requiring defined compliance controls)

I. Where Are We?

Page 8: Global Codes of Ethics/Conduct  Roundtable Discussion

88

I. Where Are We?

Page 9: Global Codes of Ethics/Conduct  Roundtable Discussion

99

• Industry Scrutiny in the Orthopedic Sector

• Novel deferred/non-prosecution agreements

• Monitors installed within each company

• Strict compliance controls

• Companies required to post all MD payments on websites

II. Where Are We Going?

Page 10: Global Codes of Ethics/Conduct  Roundtable Discussion

10

10. The Company shall adhere to the AdvaMed Code of Ethics on Interactions with Health Care Professionals. The AdvaMed Code can be found at www.advamed.org. The principles set forth in the AdvaMed Code are expressly incorporated as compliance requirements under this DPA.

Deferred Prosecution Agreements• AdvaMed Code made legally binding on on signatory companies

II. Where Are We Going?

Page 11: Global Codes of Ethics/Conduct  Roundtable Discussion

1111

• Critical Media• Federal (and State) Physician Payment Disclosure Legislation• Inquiries from Senator Grassley into transparency of companies’ charitable giving• Whistle blower laws• Other US and Global Codes Continue to Evolve Beyond Existing Footprint • IOM Public Hearing on industry conflicts of interest• AAMC issues report on industry funding of medical education

II. Where Are We Going?

Other External Factors Bearing on AdvaMed Code

Page 12: Global Codes of Ethics/Conduct  Roundtable Discussion

12

• Spring 2008: Reconstituted Code of Ethics Work Group Formed to Review and Develop Proposed Revisions to Code of Ethics (COE)

• Current Activities:– Code Review Process– “Enforcement”

II. Where Are We Going?

Page 13: Global Codes of Ethics/Conduct  Roundtable Discussion

13

2008 COE Work Group Member Companies:

II. Where Are We Going?

•Covidien•CR Bard•Edwards LifesciencesEndocare•Gambro BCT•GE•Hill-Rom•Hospira•Integra LifeSciences•Johnson & Johnson•Kensey Nash•Medtronic•Roche Diagnostics

•Abbott Laboratories•Alcon Laboratories•Advanced Medical Optics•American Medical Systems•Bausch & Lomb•Baxter•BD•Beckman Coulter•Biomet•Biotronik•Boston Scientific•Cardinal Health•Convatec

•RTI Biologics•Siemens•Smith & Nephew•Smiths Medical•Sorin Group•St. Jude Medical•Stryker•Terumo Medical•WL Gore•Zimmer

Page 14: Global Codes of Ethics/Conduct  Roundtable Discussion

1414

Possible COE Updates include:

• Product Evaluations/Samples

• Royalty FAQ

• Consulting

• Research Grants v. Charitable Contributions

II. Where Are We Going?

Page 15: Global Codes of Ethics/Conduct  Roundtable Discussion

15

Thank You!

Christopher WhiteExec. Vice Pres., General Counsel and Secretary

[email protected]